Detalhe da pesquisa
1.
Pitavastatin to Prevent Cardiovascular Disease in HIV Infection.
N Engl J Med
; 389(8): 687-699, 2023 Aug 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-37486775
2.
Changes in Body Mass Index with Longer-term Integrase Inhibitor Use: A Longitudinal Analysis of Data from the Randomized Trial to Prevent Vascular Events in Human Immunodeficiency Virus (REPRIEVE).
Clin Infect Dis
; 76(11): 2010-2013, 2023 06 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36825498
3.
Cytomegalovirus Immunoglobulin G (IgG) Titer and Coronary Artery Disease in People With Human Immunodeficiency Virus (HIV).
Clin Infect Dis
; 76(3): e613-e621, 2023 02 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35975297
4.
Sex Differences in Subclinical Atherosclerosis and Systemic Immune Activation/Inflammation Among People With Human Immunodeficiency Virus in the United States.
Clin Infect Dis
; 76(2): 323-334, 2023 01 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-36101518
5.
Pericoronary Adipose Tissue Density, Inflammation, and Subclinical Coronary Artery Disease Among People With HIV in the REPRIEVE Cohort.
Clin Infect Dis
; 77(12): 1676-1686, 2023 12 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37439633
6.
COVID-19 Vaccination Rates in a Global HIV Cohort.
J Infect Dis
; 225(4): 603-607, 2022 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34794178
7.
Geographical Differences in the Self-Reported Functional Impairment of People With Human Immunodeficiency Virus (HIV) and Associations With Cardiometabolic Risk.
Clin Infect Dis
; 75(7): 1154-1163, 2022 09 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-35165682
8.
Factors Associated With Systemic Immune Activation Indices in a Global Primary Cardiovascular Disease Prevention Cohort of People With Human Immunodeficiency Virus on Antiretroviral Therapy.
Clin Infect Dis
; 75(8): 1324-1333, 2022 10 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35235653
9.
Trial Update of Pitavastatin to Prevent Cardiovascular Events in HIV Infection.
N Engl J Med
; 390(17): 1626-1628, 2024 May 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38692296
10.
Cardiovascular Risk and Health Among People With Human Immunodeficiency Virus (HIV) Eligible for Primary Prevention: Insights From the REPRIEVE Trial.
Clin Infect Dis
; 73(11): 2009-2022, 2021 12 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34134131
11.
Pitavastatin and Cardiovascular Disease in HIV. Reply.
N Engl J Med
; 389(21): e46, 2023 Nov 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-37991868
12.
Leveraging a Landmark Trial of Primary Cardiovascular Disease Prevention in Human Immunodeficiency Virus: Introduction From the REPRIEVE Coprincipal Investigators.
J Infect Dis
; 222(Suppl 1): S1-S7, 2020 07 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32645161
13.
Physical Function Impairment and Frailty in Middle-Aged People Living With Human Immunodeficiency Virus in the REPRIEVE Trial Ancillary Study PREPARE.
J Infect Dis
; 222(Suppl 1): S52-S62, 2020 07 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32645163
14.
Characteristics of REPRIEVE Trial Participants Identifying Across the Transgender Spectrum.
J Infect Dis
; 222(Suppl 1): S31-S40, 2020 07 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32645160
15.
Patterns of Antiretroviral Therapy Use and Immunologic Profiles at Enrollment in the REPRIEVE Trial.
J Infect Dis
; 222(Suppl 1): S8-S19, 2020 07 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32645162
16.
A Randomized, Double-blinded, Placebo-controlled Trial of Sitagliptin for Reducing Inflammation and Immune Activation in Treated and Suppressed Human Immunodeficiency Virus Infection.
Clin Infect Dis
; 69(7): 1165-1172, 2019 09 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-30535188
17.
Antiretroviral Concentrations in Hair Strongly Predict Virologic Response in a Large Human Immunodeficiency Virus Treatment-naive Clinical Trial.
Clin Infect Dis
; 68(6): 1044-1047, 2019 03 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30184104
18.
Safety and Impact of Low-dose Methotrexate on Endothelial Function and Inflammation in Individuals With Treated Human Immunodeficiency Virus: AIDS Clinical Trials Group Study A5314.
Clin Infect Dis
; 68(11): 1877-1886, 2019 05 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-30219823
19.
Rationale and design of the Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE).
Am Heart J
; 212: 23-35, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30928825
20.
Changes in Markers of T-Cell Senescence and Exhaustion With Atazanavir-, Raltegravir-, and Darunavir-Based Initial Antiviral Therapy: ACTG 5260s.
J Infect Dis
; 214(5): 748-52, 2016 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27354367